Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% Sodium Chloride for Post-operative Dysphagia in ACDF
NCT03677310Phase 1Withdrawn
- Sponsor
- University of Missouri
- Start
- Apr 2018
- Primary completion
- Nov 2019
01
Overview
Phase 1, randomised, double-blind trial of sodium chloride in dysphagia (2 arms), sponsored by University of Missouri. Primary endpoint: Post-operative Dysphagia Score at 12 weeks. Planned start Apr 2018; status: withdrawn.
02
Drugs
sodium chloride
03
Conditions
dysphagia
Beyond the preview
Go deeper on NCT03677310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677310.